Bharat Biotech on Thursday said it has ramped up additional manufacturing capacities for the Covaxin covid-19 jabs as the country…
The Phase 2-3 clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI),…
The Centre released a statement on Wednesday saying, “Union Health Ministry has again written to the States and UTs on…
With several states complaining of vaccine shortage, the Centre on Saturday stated that the plan is to ramp up the…
As Bharat Biotech's Covaxin will now be manufactured by two public sector undertakings, the Centre on Saturday said that private…
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…
A direct supply of Bharat Biotech’s Covaxin has been commenced to 14 states with effect from May 1, said Suchitra…
In a recent announcement made by Bharat Biotech, the price of its Covid-19 vaccine, Covaxin has been reduced from Rs.…
India’s two Covid-19 vaccines, Covishield and Covaxin have shown efficacy against the Indian strain and have show milder infection after…
After Serum Institute, Bharat Biotech has announced that it will sell its Covid-19 vaccine, Covaxin at Rs. 600 to state…